Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Ultimovacs strengthens clinical validation of UV1 in Q2

Q2 was all about increasing momentum in the clinic for Norwegian Ultimovacs. The company’s universal cancer vaccine UV1 has progressed steadily in one of its phase I trials and in its four phase II trials. CEO Carlos de Sousa joined BioStock for a comment on the newly released report.Read the interview with Carlos de Sousa at biostock.se: https://www.biostock.se/en/2021/08/ultimovacs-strengthens-clinical-validation-of-uv1-in-q2/ This is a press release from BioStock - Connecting Innovation & Capital.

Bricknode accelerates international expansion with key hires in the UK

Bricknode today announced the appointment of two UK hires to support international expansion and increasing demand for its cloud banking solutions. Joel Cope joins the Swedish-based fintech company as Head of Marketing and Barry White has been appointed as Sales Manager.Joel Cope, who joins the company as Head of Marketing, will be responsible for expanding Bricknode’s brand presence and market opportunity. Cope brings a wealth of marketing experience having contributed to several rapid-growth companies in the financial services and fintech industries including Thomson Reuters, Moody’s

Invitation to Clas Ohlson’s Q1 presentation on 8 September

Clas Ohlson will publish the interim report for the first quarter 2021/22 on 8 September at 7:00 a.m. CET. A webcasted presentation of the report will be held at 9:00 a.m. CET the same day.Clas Ohlson invites investors, financial analysts and the media to a webcasted presentation of the interim report for the first quarter 2021/22 on Wednesday 8 September at 9:00 a.m. CET where President and CEO Kristofer Tonström and CFO Pär Christiansen will comment on the report. The interim report for the period May to July 2021/22 will be published at 7:00 a.m. CET and the report and presentation

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

York, UK and Uppsala, Sweden (August 25, 2021) Aptamer Group Ltd , the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB , the developer and manufacturer of leading-edge agarose-based purification technologies, today announce that they have entered into an agreement to co-develop a new affinity resin for improved purification and scale up of gene therapy vectors.  Under the agreement, Aptamer Group will develop an Optimer™ ligand capable of

Frontline Colombian team fights COVID-19 with ECMO therapy

Extracorporeal Membrane Oxygenation (ECMO) – providing the body with oxygen when the lungs fail to perform this task – is one of the key pillars in the treatment of severely ill COVID-19 patients. Combined with the professional expertise of the Colombian thoracic surgeon Diego Pardo, it has been an important tool in his efforts to save lives across the region.   As president of the Colombian Association of Thoracic Surgery, Dr. Pardo, also a licensed physician, is one of the country's leading authorities in the area and a pioneer in using ECMO therapy, which is used to keep

Valmet to invest in a new service center in Guangxi, China

Valmet Oyj’s press release on August 25, 2021 at 11:00 a.m. EETValmet will build its fourth service center in China, in the city of Beihai, to further develop its local presence in the fast-growing pulp and paper industry in the Guangxi province. Valmet's new Guangxi Service Center will be in operation by the fourth quarter in 2023. Valmet’s new service center will serve pulp, board, paper and tissue customers close by with main focus on roll maintenance, fiber equipment services and field services including shutdown planning management.   “Guangxi Zhuang Autonomous Region is a fast-

SynAct strengthens IP portfolio – Grant of key European patent covering AP1189

SynAct Pharma AB ("SynAct") today announced that a European patent was granted covering the company’s leading drug candidate AP1189 in methods of treating kidney diseases.SynAct has received information that its European patent EP 3 743 064 B1 was granted on 11 August 2021. The European patent provides exclusivity on the medical use of AP1189 and similar compounds in treating kidney disease, specifically primary nephrotic syndrome, and including membranous nephropathy which is currently being tested in clinical trials. The European patent will now be validated in selected European

Invitation to SAS’ Q3 2021 teleconference

SAS will publish the interim report for the third quarter of the fiscal year 2021 on Wednesday, 1[st] of September 2021, at approximately 08.00 AM (CET). A teleconference and webcast for investors, analysts and media will be held at 10.00 AM (CET). Anko van der Werff, President & CEO and Magnus Örnberg, Executive Vice President & CFO will present and comment the report. The presentation will be held in English via telephone or https://www.sasgroup.net No advance notification is necessary. Dial-in details for the conference call: DK: +45 354 455 77FI: +358 981 710 310NO:

SSG – Disclosure of large shareholding

Reference is made to the stock exchange notification on 24 August 2021 from Self Storage Group ASA (the “Company”) regarding a private placement of NOK 10,350,000 new shares (the "New Shares") in the Company (the “Private Placement”) at a subscription price of NOK 29 per share. Centerbridge Partners L.P has been allocated 3,620,000 new shares in the Private Placement. After completion of the Private Placement, Centerbridge Partners L.P will hold 24,557,078 shares in the Company, which, after issue and registration of the New Shares, will represent approximately 25.94% of the total issued

TOMRA: Mandatory notification of trade

Harald Henriksen, Executive Vice President, Head of TOMRA Collection Solutions and primary insider of TOMRA Systems ASA, has today sold 14,000 shares in TOMRA Systems ASA at a price of NOK 510.00 per share. After the transaction Harald Henriksen holds 41,052 shares in TOMRA Systems ASA.   This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Financial report for the period January 1 2021 – June 30 2021

Company Announcement No. 9-2021 OrderYOYO A/SInside Information   Copenhagen, August 25, 2021Financial Highlights – strong net revenue growth of 82% H1 2021 vs H1 2020 · Strong net revenue growth H1 2021 vs H1 2020 of 82% - to DKK 53.6m in H1 2021 · Strong ARR growth based in June 2021 compared to June 2020 of 31% - to DKK 105.4m · Solid GMV growth H1 2021 vs H1 2020 of 37% - to DKK 606m · GMV June 2021 as expected – June 2021 was the first month where Covid restrictions were lifted in all our markets which as expected meant a minor slowdown in the growth in take-

Invitation to presentation of Sectra’s three-month interim report 2021/2022

Linköping – August 25, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites analysts, investors, and the media to a presentation of the company’s three-month report with President Torbjörn Kronander and CFO Mats Franzén.Publication of the interim report: 8:15 a.m. (CEST) on September 3, 2021Report presentation: 10:00 a.m. (CEST) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q12122 . The broadcast

Anifera receives further investment from Stonehaven Incubate to initiate additional studies of adjunct therapy in bovine mastitis

· Bovine mastitis is a major economic and welfare challenge for the global dairy industry, reducing both milk yield and quality · Anifera’s unique mode of action aims to improve antibiotic efficacy and ultimately reduce the overall use of antibiotics in multiple disease statesLondon, UK, 25 August 2021 – Anifera, a company focused on developing adjunct therapy to improve the efficacy of antibiotics used in animal health, today announced that it plans to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis, a significant economic and

Launch of Pay by 24SevenOffice

24SevenOffice is pleased to announce the re-launch of the digital payment technology (previously called OptinPay) acquired from Optin Bank ASA. The digital payment solution has been named Pay by 24SevenOffice and is now in production. Since the acquisition of the technology 24SevenOffice has successfully managed to transfer the comprehensive technology platform, including taking over the hosting, re-negotiated necessary agreements and adapting the platform to the new situation.The first version of the payment solution includes flexible payment options through SMS, with card payment, mobile

NENT Group orders ‘Ida Takes Charge’ as latest Viaplay Original

· Series based on Kjersti Halvorsen’s acclaimed debut novel · ‘Ida Takes Charge’ stars Elli Rhiannon Müller Osborne (‘Psychobitch’; ‘Utøya: July 22’) and is directed by Student Academy Award winner Rikke Gregersen · NENT Group to premiere at least 50 original productions in 2021 ‘Ida Takes Charge’, a darkly humorous Norwegian drama series based on the critically acclaimed debut by young novelist Kjersti Halvorsen and directed by rising star Rikke Gregersen, will be the next Viaplay Original from Nordic Entertainment Group (NENT Group). The eight-part series stars Elli Rhiannon

Holmström Fastigheter investigates the possibility to issue subsequent bonds

Holmström Fastigheter Holding AB (publ) (”Holmström Fastigheter”) has mandated Nordea and Pareto as ’joint bookrunners’ to investigate the possibility of issuing subsequent senior unsecured bonds (the “New Bonds”), under its existing bond framework of SEK 750,000,000 with ISIN: SE0015797667. Holmström Fastigheter has, as previously published, on 14 April 2021, issued SEK 300,000,000 under the bond framework. A market transaction may follow, subject to market conditions. The net proceeds from the New Bonds will be used for general corporate purposes including acquisition of properties.

"myFC is targeting a rapidly growing billion-dollar market" – Tim Hannig, senior Business Advisor at myFC

According to Tim Hannig, Senior Business Advisor to the board of management of myFC, with a background in Kion group, Jaguar Land Rover, and other OEM companies, myFC is taking important steps to future business agreements with a leading OEM that develops automatic warehouse robots.– Intralogistics is an exciting and commercially significant segment where myFC’s technology also provides crucial benefits. myFC is entering a rapidly growing market with a strong market drive, he says.Intralogistics appears to be an expansive business area; can you tell us more?– One reason for the rapid

Kristina Olsen to leave Bonava

Kristina Olsen has decided to leave Bonava and her role of BU President of Bonava Norway to work with an external assignment. Jonas Granström has been appointed Acting BU President and member of the Executive Management Group.Kristina Olsen has worked at NCC/Bonava since 2000 and held several senior positions at the company, including as BU President Bonava Denmark-Norway. She has been a member of Bonava’s Executive Management Group since 2018. – I would like to extend my sincere gratitude to Kristina for her highly appreciated work during her time at Bonava. I wish Kristina much success

Janes at the heart of the British Army’s first AI-driven battlefield operation

The trusted global agency for open-source defence intelligence is proud to have played a major role in the first use of Artificial Intelligence on deployed operations by the British Army during Exercise ‘Spring Storm’.LONDON (25 August 2021) – Interconnecting with third-party data and systems, Janes foundational intelligence was integral during the first use of Artificial Intelligence (AI) on deployed operations by the British Army. Soldiers from the 20[th] Armoured Infantry Brigade used an AI engine – incorporating Janes interconnected intelligence – to provide information on the

Safello to host a new AMA session in Discord

Stockholm, 25 August 2021 | Safello will follow up the recently published interim report for Q2 2021 with an AMA session targeting shareholders, users and other interested stakeholders in the Safello Community Discord channel. AMA (Ask Me Anything) offers a platform for Safello's broad community of users, shareholders and crypto enthusiasts to interact directly with Safello’s representatives, as well as ask any burning questions in a casual question-and-answer format. The second Community AMA session featuring CEO Frank Schuil will take place this Friday, August 27, 2021, at

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Eurocine Vaccines extends its product portfolio with a diagnostic test of chlamydia through a widened agreement with Spixia Biotechnology

Eurocine Vaccines AB has decided to evaluate a diagnostic test of chlamydia antibodies in blood as an extension of its portfolio and has widened the license agreement with Spixia Biotechnology AB to also include diagnostic tests of chlamydia.Chlamydia is a sexually transmitted bacterial disease that often leads to involuntary infertility in women (read more ). There is currently no prophylactic vaccine against chlamydia on the market and Eurocine Vaccines is developing a vaccine candidate based on a patented protein (read more 

STRAX: Interim Report No 2 for the financial year 2021

STRAX have again managed well through a period of continued market disruption related to the Covid-19 pandemic· The Group’s sales for the period January 1 – June 30, 2021, amounted to MEUR 54.8 (50.2), with a gross margin of 19.0 (23.7) percent.  · The Group’s result for the period January 1 – June 30, 2021, amounted to MEUR -2.0 (-2.8) corresponding to EUR -0.02 (-0.02) per share.  · EBITDA for the period January 1 – June 30, 2021, amounted to MEUR 1.6 (1.4). · Equity as of June 30 2021, amounted to MEUR 16.2 (17.3) corresponding to EUR 0.13 (0.15) per share. · STRAX

There are no items matching the current filter
There are no more items matching the current filter
Back to top